- About
- Partner Centers
- People
- Project ECHO for ILD
- Curriculum
- Acute Exacerbations of ILD
- Hypersensitivity Pneumonitis: Approach and Challenges
- Idiopathic Pulmonary Fibrosis: A Diagnostic Approach
- Idiopathic Pulmonary Fibrosis: Natural History and Survival
- Lung Biopsy in the Diagnosis of Fibrotic ILD
- More Than Meds: Nonpharmacologic Treatments for ILD
- Myositis-Associated ILD: Clinical Manifestations and Diagnosis
- Myositis-Associated ILD: Treatment Approaches and Challenges
- Overview of Autoimmune ILD
- Post-acute Sequelae of COVID-19 (PASC)
- Pulmonary Hypertension Associated with ILD
- Rethinking Classification Criteria for Connective Tissue Diseases
- Sarcoidosis: Overview, Diagnosis and Monitoring
- Scleroderma-Associated ILD: Clinical Manifestations and Diagnosis
- Scleroderma-Associated ILD: Treatment Approaches and Challenges
- Treatments for Idiopathic Pulmonary Fibrosis
- Shifting Paradigms of IPF Pathogenesis
- Registration
- Curriculum
- Virtual Meetings
- Anesthesia for People With Interstitial Lung Disease
- Art Therapy in Chronic Illness
- Gastroesophageal Reflux Disease (GERD) and ILD
- Interstitial Lung Disease: The Journey to Diagnosis and Treatment
- Lung Transplant: Eligibility and Evaluation
- The Lived Experience Series: Financial and Tax Planning
- Updates on Clinical Research for IPF and Other Forms of ILD
- Resources
- Aspirational Patient Journey
- Basics of ILDs
- Basics of IPF
- Blog
- Genetics of Familial Idiopathic Interstitial Pneumonia
- IPF Patient Journey
- IPF and PF-ILD Clinical Trials
- Monitoring Disease Progression in Idiopathic Pulmonary Fibrosis
- Patient Symposium
- Peer To Peer Support
- Phase IV IPF Clinical Trials
- Pulmonary Function Testing
- Starting Oxygen Therapy
- Support Groups
- Webinars
- Clinical Trials